Skip to main content
SRTAStrata Critical Medical, Inc.Sell6.0·$5.43+2.84%
Open full analysis

Strata Critical Medical, Inc. (SRTA) Stock Analysis

Range Bound setup · Inst Constrain edge

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $5.43: Quality below floor (2.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality.

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human... Read more

$5.43+45.3% A.UpsideScore 6.0/10#7 of 36 Medical Care Facilities
QualityF-score3 / 9FCF yield-5.12%
Stop $5.03Target $7.86(analyst − 15%)A.R:R 4.3:1
Analyst target$9.25+70.3%4 analysts
$7.86our TP
$5.43price
$9.25mean
$12

Sell if holding. Engine safety override at $5.43: Quality below floor (2.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality. Chart setup: RSI 48 mid-range, Bollinger mid-band. Score 6.0/10, moderate confidence.

Passes 7/9 gates (positive momentum, favorable risk/reward ratio, no SEC red flags, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202631d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (2.8 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)
Mkt Cap$468M
EV/EBITDA-3761.7
Profit Mgn20.6%
ROE-6.4%
Rev Growth87.4%
Beta2.22
DividendNone
Rating analysts10

Quality Signals

Piotroski F3/9

Options Flow

IV47%normal

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·2 ceiling hits

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Fcf Quality
0.0
Gross Margin
0.2
Piotroski F
3.3
Moat
4.2
Current Ratio
7.1
Net Margin
10.0
Strong margins: 21%Earnings quality RED FLAG: -51% FCF/NINo competitive moatWeak Piotroski F-Score: 3/9Quality concerns

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Surprise Avg
0.0
Earnings History
3.3
Erm
5.0
Earnings Timing
5.0
Earnings concerns: 2B/2M
GatesMomentum 5.0<5.5 (soft — BUY_NOW allowed but watch)INSIDER 0.17%=MODERATEMomentum 5.0>=4.5A.R:R 4.3 ≥ 1.5No SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 31d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
48 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $5.08Resistance $6.42

Price Targets

$5
$8
A.Upside+44.8%
A.R:R4.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (2.8 < 4.0)

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-04 (31d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is SRTA stock a buy right now?

Sell if holding. Engine safety override at $5.43: Quality below floor (2.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 4.3:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality. Chart setup: RSI 48 mid-range, Bollinger mid-band. Prior stop was $5.03. Score 6.0/10, moderate confidence.

What is the SRTA stock price target?

Take-profit target: $7.86 (+45.3% upside). Prior stop was $5.03. Stop-loss: $5.03.

What are the risks of investing in SRTA?

Quality below floor (2.8 < 4.0).

Is SRTA overvalued or undervalued?

Strata Critical Medical, Inc. trades at a P/E of N/A (forward N/A). TrendMatrix value score: 9.0/10. Verdict: Sell.

What do analysts say about SRTA?

10 analysts cover SRTA with a consensus score of 4.2/5. Average price target: $9.

What does Strata Critical Medical, Inc. do?Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the...

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Related stocks: NUTX (Nutex Health Inc.) · TOI (The Oncology Institute, Inc.) · ARDT (Ardent Health, Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · ASTH (Astrana Health Inc.)
Home Stocks SRTA

Latest news

No recent news